Berries aren’t just a delicious cereal topping or perfect midday snack: Every few months, news outlets and websites pick up on new research into…
Dr. Tom Oxley has been obsessed with the brain since he was 13. “I studied medicine, because I just wanted to learn about the…
On Monday, revealed that a phase 3 study of brexpiprazole — brand name Rexulti — in Alzheimer’s patients showed that the drug for major…
There were more than 140 experimental Alzheimer’s drugs in clinical trials as of the start of 2022. On the one hand, this number inspires…
UPDATE: 3 March 2024, 8:35 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
By 2050, it is estimated that 153 million people worldwide — more than one in every 100 — will be living with Alzheimer’s. While the…
How can a chronic condition originating from the pancreas double your risk of developing Alzheimer’s or dementia? According to the Centers for Disease Control…
More than 60 percent of people with dementia are also diagnosed with depression. In some cases, studies indicate that depression might even cause the…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Shonda Bell — a special education…
Providing medical aid in dying (MAID) — sometimes referred to as “death with dignity” — is fraught with both legal and ethical concerns. Yet,…
Vaccines are considered one of the greatest innovations in medical history. Immunizations help train the body’s immune system to recognize and respond to a…
This Alzheimer’s drug has already been approved for use in China. The clinical trials that could lead to approval in the U.S. have just…
UPDATE: 3 March 2024, 8:30 P.M. ET. In February 2024, Biogen took Aduhelm off the market, citing financial concerns. Although the drug did receive…
Human clinical trials kick off for Protollin, an experimental Alzheimer’s vaccine. After two decades of research and development, Brigham and Women’s Hospital has initiated…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Dave Balbridge grew up in Los…